Genetic determinants and an epistasis of LILRA3 and HLA-B(star)52 in Takayasu arteritis
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Authors: Terao, Chikashi; Yoshifuji, Hajime; Matsumura, Takayoshi; Naruse, Taeko K.; Ishii, Tomonori; Nakaoka, Yoshikazu; Kirino, Yohei; Matsuo, Keitaro; Origuchi, Tomoki; Shimizu, Masakazu; Maejima, Yasuhiro; Amiya, Eisuke; Tamura, Natsuko; Kawaguchi, Takahisa; Takahashi, Meiko; Setoh, Kazuya; Ohmura, Koichiro; Watanabe, Ryu; Horita, Tetsuya; Atsumi, Tatsuya; Matsukura, Mitsuru; Miyata, Tetsuro; Kochi, Yuta; Suda, Toshio; Tanemoto, Kazuo; Meguro, Akira; Okada, Yukinori; Ogimoto, Akiyoshi; Yamamoto, Motohisa; Takahashi, Hiroki; Nakayamada, Shingo; Saito, Kazuyoshi; Kuwana, Masataka; Mizuki, Nobuhisa; Tabara, Yasuharu; Ueda, Atsuhisa; Komuro, Issei; Kimura, Akinori; Isobe, Mitsuaki; Mimori, Tsuneyo; Matsuda, Fumihiko
Abstract
Takayasu arteritis (TAK) is a systemic vasculitis with severe complications that affects the aorta and its large branches. HLA-B(star)52 is an established susceptibility locus to TAK. To date, there are still only a limited number of reports concerning non-HLA susceptibility loci to TAK. We conducted a genome-wide association study (GWAS) and a follow-up study in a total of 633 TAK cases and 5,928 controls. A total of 510,879 SNPs were genotyped, and 5,875,450 SNPs were imputed together with HLA-B(star)52. Functional annotation of significant loci, enhancer enrichment, and pathway analyses were conducted. We identified four unreported significant loci, namely rs2322599, rs103294, rs17133698, and rs1713450, in PTK2B, LILRA3/LILRB2, DUSP22, and KLHL33, respectively. Two additional significant loci unreported in non-European GWAS were identified, namely HSPA6/FCGR3A and chr21q.22. We found that a single variant associated with the expression of MICB, a ligand for natural killer (NK) cell receptor, could explain the entire association with the HLA-B region. Rs2322599 is strongly associated with the expression of PTK2B. Rs103294 risk allele in LILRA3/LILRB2 is known to be a tagging SNP for the deletion of LILRA3, a soluble receptor of HLA class I molecules. We found a significant epistasis effect between HLA-B(star)52 and rs103294 (P = 1.2 x 10(-3)). Enhancer enrichment analysis and pathway analysis suggested the involvement of NK cells (P = 8.8 x 10(-5), enhancer enrichment). In conclusion, four unreported TAK susceptibility loci and an epistasis effect between LILRA3 and HLA-B(star)52 were identified. HLA and non-HLA regions suggested a critical role for NK cells in TAK.
JNK Pathway-associated Phosphatase Dephosphorylates Focal Adhesion Kinase and Suppresses Cell Migration
JOURNAL OF BIOLOGICAL CHEMISTRY
Authors: Li, Ju-Pi; Fu, Yu-Ning; Chen, Yi-Rong; Tan, Tse-Hua
Abstract
JNK pathway-associated phosphatase (JKAP, also named DUSP22) is expressed in various tissues, indicating that JKAP may have an important biological function. We showed that JKAP localized in the actin filament-enriched region. Expression of JKAP reduced cell migration, whereas a JKAP mutant lacking catalytic activity promoted cell motility. JKAP efficiently removed tyrosine phosphorylation of several proteins. We have identified focal adhesion kinase (FAK) as a substrate of JKAP. Overexpression of JKAP, but not JKAP mutant lacking catalytic activity, decreased FAK phosphorylation at tyrosines 397, 576, and 577 in H1299 cells. Consistent with these results, decreasing JKAP expression by RNA interference promoted cell migration and Src-induced FAK phosphorylation. Taken together, this study identified a new role for JKAP in the modulation of FAK phosphorylation and cell motility.